CME for Reviewers

The Journal of Diabetes with Wiley now offers continuing medical education (CME) credit for peer review of manuscripts submitted to the journal. Peer reviewers may request 3.0 AMA PRA Category 1 Credits™ per original manuscript being reviewed. Reviewers may only claim CME credit once per manuscript. Credit claims for additional rounds of review will not be awarded.

To submit a request for CME credit, the manuscript reviewer must complete the required CME questions within their review submission form online. Following submission, your request for credit will then be processed. Please note that requests for CME credit are only possible during initial submission of your review.

Certificates for all approved requests will be issued out by email on a monthly basis. A copy of your certificate will be held on file by the accredited provider for later access. If you require a replacement copy of your certificates, or if you have any questions regarding the program, please contact the accredited provider at [email protected].

Click here to learn more about the peer review process.

Educational Objective

Upon the completion of this activity, reviewers will be better able to identify and evaluate novel concepts and research pertaining to diabetes and related conditions.

Activity Disclosures

No commercial support has been accepted related to the development or publication of this activity.

Faculty and Disclosures

Editor-in-Chief
Zachary T. Bloomgarden discloses the following relevant financial relationships: Honoraria recieved for his role as consultant/advisor from Sanofi, Astra Zeneca, Janssen, Merck, Intarcia, and Novartis; Honoraria fees for his role as speaker from Amgen, Merck, Astra Zeneca, and Janssen; and he is a stockholder of Allergan, Zimmer Biomet and Novartis.
Guang Ning reported no conflicts of interest or relevant financial relationships.

Associate Editors

Daniel Einhorn discloses the following relevant financial relationships: Consulting fees and clinical research received from Adocia, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi, Takeda, and Janssen for his role as consultant and honoraria received from Abbott for his role as speaker.
George Grunberger discloses the following relevant financial relationships: Research contract from Medtronic and Novo Nordisk for his role as investigator; and honoraria received from Novo Nordisk, Eli Lilly, Janssen, Boehringer Ingelheim, Sanofi and Astra Zeneca for his role as speaker.
Yehuda Handelsman discloses the following relevant financial relationships: Research grants from Amgen, Astra Zeneca, BMS, Boehringer Ingelheim, Grifols, Janssen, Lexicon, Merck, Novo Nordisk, and Sanofi; Advisory/consultant for Amarin, Amgen, Astra Zeneca, Boehringer Ingelheim, Eisai, Intarcia, Lilly, Janssen, Merck, Merck-Pfizer, Novo-Nordisk, Regeneron, and Sanofi; Speaker’s Bureau from Amarin, Amgen, Astra Zeneca, BI- Lilly, Janssen, Merck, Novo-Nordisk, Sanofi, and Regeneron.
Anoop Misra discloses the following relevant financial relationships: Consultant/advisor for Novartis, Johnson & Johnson, and Boehringer Ingelheim; and speaker for Lupin, AstraZeneca, Novartis, and Glanmark.

Robert Rapaport discloses the following relevant financial relationships: consulting for Sandoz and Novo. Andrew J. Drexler, You-Fei Guan, Xiao-Ying Li, Jian-Min Liu, Guang Ning, Wei-Qing Wang, Jian-Ping Weng and Dalong Zhu reported no conflicts of interest or relevant financial relationships.

Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.

Accreditation

John Wiley and Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this manuscript review activity for a maximum of 3.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.